Agoda Recommends the Best Destinations to Beat the Heat This Summer

SINGAPORE, July 2, 2026 /PRNewswire/ — As temperatures rise across Europe and…

Trane Launches HSWE Magnetic Bearing Chiller to Advance Data Center Cooling Across Asia Pacific

SHANGHAI, July 2, 2026 /PRNewswire/ — Trane – by Trane Technologies (NYSE:…

Chulalongkorn University President Elected Head of Asian Universities Alliance

ASTANA, Kazakhstan, July 2, 2026 /PRNewswire/ — Professor Dr. Wilert Puriwat, President…

ICAC Commissioner attends first IAACA European regional anti-corruption conference in Hungary

BUDAPEST, Hungary, July 2, 2026 /PRNewswire/ — ICAC Commissioner, Mr Woo Ying-ming,…

Gprnt Partners SGX Group to Strengthen Climate Reporting, Transition Planning, and Help Companies Build Long-Term Competitiveness on ESGenome

Announced at the inaugural SGX Group-Gprnt Climate Action Forum Streamlines and simplifies…

Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH

SUZHOU, China and MÖLNDAL, Sweden, July 2, 2026 /PRNewswire/ — Suzhou Ribo…

Trinasolar Showcases Vertex N G3 at ASEW to Support Thailand's Solar Market Amid Rising AI and Data Centre Demand

Thailand’s solar market is growing rapidly, driven by the PDP 2026 target…

Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC

SHANGHAI, July 2, 2026 /PRNewswire/ — Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics"…